Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.74
+0.26 (4.01%)
At close: Jun 6, 2025, 4:00 PM
6.83
+0.09 (1.34%)
After-hours: Jun 6, 2025, 6:19 PM EDT

Abeona Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
--3.51.41310
Upgrade
Revenue Growth (YoY)
--147.53%-52.87%-70.00%-
Upgrade
Cost of Revenue
34.3634.3632.729.4238.7330.14
Upgrade
Gross Profit
-34.36-34.36-29.2-28-35.73-20.14
Upgrade
Selling, General & Admin
32.5129.851917.2621.6423.78
Upgrade
Research & Development
2.73-----
Upgrade
Operating Expenses
35.2529.851917.2621.6428.37
Upgrade
Operating Income
-69.61-64.21-48.2-45.26-57.37-48.5
Upgrade
Interest Expense
-4.25-4.21-0.42-0.74-3.66-4.12
Upgrade
Interest & Investment Income
4.714.252.120.430.041.3
Upgrade
Other Non Operating Income (Expenses)
24.960.44-8.7111.660.02-
Upgrade
EBT Excluding Unusual Items
-44.19-63.74-55.21-33.9-60.97-51.32
Upgrade
Impairment of Goodwill
-----32.47-
Upgrade
Gain (Loss) on Sale of Assets
00-0.05-0.14--
Upgrade
Asset Writedown
--1.07-5.66--32.92
Upgrade
Other Unusual Items
----8.5-
Upgrade
Pretax Income
-44.19-63.73-54.19-39.7-84.94-84.23
Upgrade
Net Income
-44.19-63.73-54.19-39.7-84.94-84.23
Upgrade
Preferred Dividends & Other Adjustments
---3.78--
Upgrade
Net Income to Common
-44.19-63.73-54.19-43.48-84.94-84.23
Upgrade
Shares Outstanding (Basic)
474121844
Upgrade
Shares Outstanding (Diluted)
474121844
Upgrade
Shares Change (YoY)
94.57%91.99%171.96%99.65%6.24%84.02%
Upgrade
EPS (Basic)
-0.95-1.55-2.53-5.53-21.57-22.73
Upgrade
EPS (Diluted)
-0.95-1.55-2.53-5.53-21.57-22.73
Upgrade
Free Cash Flow
-63-58.46-37.34-43.61-69.82-36.36
Upgrade
Free Cash Flow Per Share
-1.35-1.42-1.75-5.55-17.73-9.81
Upgrade
Gross Margin
------201.39%
Upgrade
Operating Margin
---1377.14%-3200.64%-1912.33%-485.04%
Upgrade
Profit Margin
---1548.23%-3074.82%-2831.20%-842.34%
Upgrade
Free Cash Flow Margin
---1066.86%-3084.37%-2327.20%-363.55%
Upgrade
EBITDA
-67.56-62.21-45.91-42.16-54.12-43.92
Upgrade
D&A For EBITDA
2.0522.293.093.254.59
Upgrade
EBIT
-69.61-64.21-48.2-45.26-57.37-48.5
Upgrade
Revenue as Reported
-----10
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q